Effects of interleukin-1 blockers on corneal fibroblast proliferation in vitro and ocular inflammation in vivo

Journal of Ocular Pharmacology and Therapeutics

Volumn 16, Issue 1, 2000, Pages 81-96

  Liu, Qin ^a   Zhou, Yue Hua ^a   Xuan, Bo ^a   Chiou, George C Y ^a   Okawara, Tadashi ^b  

^a TEXAS A AND M UNIVERSITY SYSTEM   (United States)

^b KUMAMOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

2 BENZYL 5 [N' (4 HYDROXYBENZYLIDENE) N METHYLHYDRAZINO] 2H PYRIDAZIN 3 ONE; 2 BENZYLIDENE 1 METHYL 1 PHENYLHYDRAZINE; 3 [METHYL (2 OXO 2H CHROMEN 4 YL) HYDRAZONO] 3 PHENYLPROPIONIC ACID ETHYL ESTER; 3 [N' (4 HYDROXYBENZYLIDENE) N METHYLHYDRAZINO] 5,5 DIMETHYLCYCLOHEX 2 ENONE; 4 [N' (2,4 DIHYDROXYBENZYLIDENE) N METHYLHYDRAZINO] 6 METHYLPYRAN 2 ONE; 4 [N' (4 BROMOBENZYLIDENE) N METHYLHYDRAZINO] 6 METHYLPYRAN 2 ONE; 4 [N' (4 CHLOROBENZYLIDENE) N METHYLHYDRAZINO] 6 METHYLPYRAN 2 ONE; 4 [N' (4 DIMETHYLAMINOBENZYLIDENE) N METHYLHYDRAZINO] 6 METHYLPYRAN 2 ONE; 4 [N' (4 METHOXYBENZYLIDENE) N METHYLHYDRAZINO] 6 METHYLPYRAN 2 ONE; 5 [N' (4 HYDROXYBENZYLIDENE) N METHYLHYDRAZINO] 2 PHENYL 2H PYRIDAZIN 3 ONE; ANTIMITOTIC AGENT; CELL DNA; INTERLEUKIN 1; INTERLEUKIN BLOCKING AGENT; MESSENGER RNA; METHYLHYDRAZINE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; CELL PROLIFERATION; CONCENTRATION RESPONSE; CONFERENCE PAPER; CONTROLLED STUDY; CORNEA CELL; DNA SYNTHESIS; DOSE TIME EFFECT RELATION; DRUG EFFICACY; DRUG POTENCY; DRUG STRUCTURE; FEMALE; FIBROBLAST; MESSENGER RNA SYNTHESIS; MITOSIS INHIBITION; NONHUMAN; RABBIT; RAT; REFRACTIVE KERATOPLASTY; UVEITIS; WOUND HEALING;

EID: 0033978574     PISSN: 10807683     EISSN: None     Source Type: Journal    
DOI: 10.1089/jop.2000.16.81     Document Type: Conference Paper

References (23)

1. Lohmann, C.P. Corneal wound healing and pharmacology in excimer laser keratorefractive surgery for myopia. Refractive Surg. 10:455-472, 1997.
2. Jester, J.V., Petroll, W.M. and Cavanagh, H.D. Corneal stromal wound healing in refractive surgery: the role of myofibroblasts. Prog. Retinal Eye Res. 18:311-356, 1999.
3. Carones, F., Brancato, R. and Venturi, E. Efficacy of corticosteroids in reversing regression after myopic photorefractive keratectomy. Refract. Corneal Surg. 9(suppl):52, 1993.
4. Tengroth, B., Fagerholm, P., Soderberg, O., Hamberg-Nystrom, H. and Epstein, D. Effect of corticosteroids in postoperative care following photorefractive keratectomy. Refract. Corneal Surg. 9(suppl):61, 1993.
5. Gartry, D.S., Kerr, M.M. and Marshall, J. The effect of topical corticosteroids on refraction and corneal haze following excimer laser treatment of myopia: an update. A prospective, randomised, double-masked study. Eye 7:584-590, 1993.
6. Nassaralla, B.A., Szerenyi, K., Wang, X., Al Reaves, T. and McDonnell, P.J. Effect of diclofenac on corneal haze after photorefractive keratectomy in rabbits. Ophthalmology 102:469-474, 1995.
7. Ferrari, M. Use of topical nonsteroidal anti-inflammatory drugs after photorefractive keratectomy. Refract. Corneal Surg. 10(2 suppl):S287-289, 1994.
8. Brancato, R., Carones, F., Venturi, E. and Bertuzzi, A. Corticosteroids vs diclofenac in the treatment of delayed regression after myopic photorefractive keratectomy. Refract. Corneal Surg. 9:376, 1993.
9. West-Mays, J.A., Sadow, P.M., Tobin, T.W., Strissel, K.J., Cintrin, C. and Fini, M.E. Repair phenotype in corneal fibroblasts is controlled by an interleukin-1α autocrine feedback loop. Invest. Ophthalmol. Vis. Sci. 38:1367-1379, 1997.
10. Li, D. and Tseng, S.C.G. Differential regulation of cytokine and receptor transcript expression in human corneal and limbal fibroblasts by epidermal growth factor, transforming growth factor-α, platelet-derived growth factor b, and interleukin-1β. Invest. Ophthalmol. Vis. Sci. 37:2068-2080, 1996.
11. Moller-Pedersen, T., Cavanagh, H.D., Petroll, W.M. and Fester, J.V. Neutralizing antibody to TGF beta modulates stromal fibrosis but not regression of photoablative effect following PRK. Curr. Eye Res. 17:736-747, 1998.
12. Chiou, G.C.Y. and Liu, S.X.L. Novel non-arachidonate-mediated, non-steroidal anti-inflammatory agents. Exp. Opin. Invest. Drugs 3:725-732, 1994.
13. Chiou, G.C.Y., Chen, Z., Xuan, B., Yamasaki, T. and Okawara, T. Antagonism of interleukin-1 (IL-1)-induced uveitis with synthetic IL-1 blockers. J. Ocul. Pharmacol. Ther. 13:427-433, 1997.
14. Xuan, B., Chiou, G.C.Y., Uamasaki, T. and Okawara, T. Anti-uveitis and inhibition of fibroblast-like corneal and conjunctival cell cultures by interleukin-1 blockers, CK125, CK 126 and CK 128. Ophth. Res. 30:10-188, 1998.
15. Chiou, G.C.Y., Zhou Y., Xuan, B., Uamasaki, T. and Okawara, T. Suppression of interleukin-1α-induced uveitis and inhibition of fibroblast-like cell proliferation by synthetic interleukin-1 blockers. J. Ocul. Pharmacol. Ther. 15:351-362, 1999.
16. Yamasaki, T., Nishida, K., Okamoto, Y., Okawara, T. and Furukawa, M. A new approach to fused 1,2-diazepines by cyclization of enhydrazines with α-and β-keto esters. Heterocycles 47:315-327, 1998.
17. West-Mays, J.A., Cook, J.R., Sadow, P.M., Mullady, D.K., Bargagna-Mohan, P., Strissel, K.J. and Fini, M.E. Differential inhibition of collagenase and interleukin-1 alpha gene expression in cultured corneal fibroblasts by TGF-beta, dexamethasone, and retinoic acid. Invest. Ophthalmol. Vis. Sci. 40:887-896, 1999.
18. Fabre, E.J., Bureau, J., Pouliquen, Y. and Lorans, G. Binding sites for human interleukin-1 alpha, gamma interferon and tumor necrosis factor on cultured fibroblasts of normal cornea and keratoconus. Curr. Eye Res. 10:585-592, 1991.
19. Wilson, S.E., He, Y.G., Weng, J., Li, Q., McDowall, A.W., Vital, M. and Chwang, E.L. Epithelial injury induces keratocyte apoptosis: hypothesized role for the interleukin-1 system in the modulation of corneal tissue organization and wound healing. Exp. Eye Res. 62:325-338, 1996.
20. Xiao, J.G., Schwade, N.D. and Chiou, G.C.Y. Mechanisms of antagonism of interleukin-1α by synthetic interleukin-1 blockers. J. Ocul. Pharmacol. Ther. 11:373-382, 1995.
21. Rosenbaum, J.T. and Boney, R.S. Activity of an interleukin-1 receptor antagonist in rabbit models of uveitis. Arch. Ophthalmol. 110:547-549, 1992.
22. Tan, G.H., Dutton, C.M. and Bahn, R.S. Interleukin-1 (IL-1) receptor antagonist and soluble IL-1 receptor inhibit IL-1-induced glycosaminoglycan production in cultured human orbital fibroblasts from patients with Graves' ophthalmopathy. J. Clin. Endocrinol. Metab. 81:449-452, 1996.
23. Schwade, N.D. and Chiou, G.C.Y. Effects of interleukin-1 blockers on ophthalmic wound healing in a rabbit model of trabeculectomy. J. Ocul. Pharmacol. Ther. 11:125-134, 1995.